Switch to:
More From Other Websites
Jazz Pharmaceuticals Plc: Leads amongst peers with strong fundamentals Jan 19 2017
Can Jazz Pharmaceuticals Be a Top Choice for Value Investors? Jan 19 2017
Jazz Rebuffs Concerns Of Generic Sleep Drug Amid Patent Litigation Jan 18 2017
Wednesday’s Top Biopharma Winners Jan 18 2017
FDA Approves Generic of Jazz Pharma's Sleep Drug Jan 18 2017
Jazz Begins Phase III Study for Label Expansion of Defitelio Jan 18 2017
JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events Jan 18 2017
Neurocrine Med Failure, Jazz Pharma Generic Rival OK Sends Both Down Jan 17 2017
FDA approves generic version of Jazz Pharma's sleep disorder drug Jan 17 2017
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating... Jan 17 2017
9 Stocks Trading Below the Peter Lynch Value Jan 11 2017
Blog Coverage Alexion Pharma Applies for US and EU Marketing Approval of Refractory Generalized... Jan 10 2017
JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2017
Industrial Companies Showing Good Potential for 2017 Jan 04 2017
Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 9 Jan 03 2017
Gurus and Insiders Invest in Industrial and Medical Companies Dec 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK